Buerger's disease, also known as thromboangiitis obliterans, is a rare condition that primarily affects young to middle-aged male smokers. The veins and arteries of the extremities constrict or block ...

Buerger's disease, also known as thromboangiitis obliterans (TAO), is a non-atherosclerotic, inflammatory occlusive disease that predominantly affects small- and medium-sized arteries and veins of the ...

Buerger disease typically affects young or middle aged male cigarette smokers. The Food and Drug Administration (FDA) has granted Orphan Drug designation to AMB-301 for the treatment of Buerger ...

BASKING RIDGE, N.J., March 08, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to CLBS12, an investigational nongene-edited cell therapy for the ...

Ambulero Inc., a spinout from the University of Miami Miller School of Medicine, has received a positive response from a type B pre-IND meeting with the FDA on the development of AMB-301 as a ...

Ambulero Inc., a spinout from the University of Miami Miller School of Medicine, has received a positive response from a type B pre-IND meeting with the FDA on the development of AMB-301 as a ...